Walker-Warburg syndrome: Neurologic features and muscle membrane structure

Pediatric Neurology

Volumn 18, Issue 1, 1998, Pages 76-80

  Kanoff, Richard J ^a   Curless, Richard G ^a   Petito, Carol ^a   Falcone, Steven ^a   Siatkowski, R Michael ^a   Pegoraro, Elena ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROGLYCAN; LAMININ;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CENTRAL NERVOUS SYSTEM MALFORMATION; DEVELOPMENTAL DISORDER; EYE MALFORMATION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MEMBRANE STRUCTURE; MUSCLE FIBER MEMBRANE; MUSCULAR DYSTROPHY; NEURORADIOLOGY; PRIORITY JOURNAL; WALKER WARBURG SYNDROME;

BRAIN; EYE ABNORMALITIES; HUMANS; MALE; MEMBRANE PROTEINS; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES; SYNDROME;

EID: 0031891258     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(97)00137-9     Document Type: Article

References (17)

1. [1] Dobyns WB, Pagon RA, Armstrong D, et al. Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet 1989;32:195-210.
2. [2] Tomé FMS, Evangelista T, Leclerc A, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci 1994;317:351-94.
3. [3] Ehrig K, Leivo I, Argraves WS, et al. Merosin, a tissue-specific basement membrane protein, is a laminin-like protein. Proc Natl Acad Sci USA 1990;87:3264-8.
4. [4] Voulteenaho R, Nissinen M, Sainio K, et al. Human laminin M chair (merosin): Complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J Cell Biol 1994;124:381-94.
5. [5] Hayashi YK, Engvall E, Harikawa-Hirasawa E, et al. Abnormal localization of laminin subunits in muscular dystrophies. J Neurol Sci 1993;119:53-64.
6. [6] Haltia M, Leivo I, Somer H, et al. Muscle-eye-brain disease: A neuropathological study. Ann Neurol 1997;41:173-80.
7. [7] Voit T, Sewry CA, Meyer K, et al. Preserved merosin M-chain (or Laminin - α2) expression in skeletal muscle distinguishes Walker-Warburg Syndrome from Fukuyama Muscular Dystrophy and merosin-deficient congenital muscular dystrophy. Neuropediatrics 1995;26:148-55.
8. [8] Kukner S, Gurer Y, Saatci I, Akcoren Z, Topaloglu H. Laminin α2 chain (merosin M) is preserved in the Walker-Warburg syndrome. Neuropediatrics 1996;27:279-80.
9. [9] Koenig M, Kunkel LM. Detailed analysis of the repeat domain of dystrophin reveals 4 potential hinge regions that may confer flexibility. J Biol Chem 1990;265:4560-6.
10. [10] Dambska H, Wisniewski K, Sher JH. Lissencephaly: Two distinct clinico-pathologic types. Brain Dev 1983;5:302-10.
11. [11] Dobyns WB. Developmental aspects of lissencephaly and the lissencephaly syndromes. Birth Defects 1987;23:225-41.
12. [12] Pagon RA, Clarren SK, Milam DF Jr, Hendrickson AE. Autosomal recessive eye and brain anomalies: Warburg syndrome. J Pediatr 1983;102:542-6.
13. [13] Towfighi J, Sassani JW, Suzuki K, Ladda RL. Cerebro-ocular dysplasia-muscular dystrophy syndrome. Acta Neuropathol 1984;65: 110-23.
14. [14] Kimura S, Sasaki Y, Kobayashi T, et al. Fukuyama-type congenital muscular dystrophy and the Walker-Warburg syndrome. Brain Dev 1993;15:182-91.
15. [15] Wewer UM, Durkin ME, Zhang X, et al. Laminin β2 chain and adhalin deficiency in the skeletal muscle of Walker-Warburg syndrome (cerebro-ocular dysplasia-muscular dystrophy). Neurology 1995;45: 2099-101.
16. [16] Yoshioka M, Kuroki S, Nigami H, Kawai T, Nakamura H. Clinical variation within sibships in Fukuyama-type congenital muscular dystrophy. Brain Dev 1992;14:334-7.
17. [17] Toda T, Hoshioka M, Nakahori Y, Kanazawa I, Nakamura Y, Nakagome Y. Genetic identity of Fukuyama-type congenital muscular dystrophy and Walker-Warburg syndrome. Ann Neurol 1995;37:99-101.